Composition
- Active ingredients
- LAMIVUDINE 150MG; RALTEGRAVIR POTASSIUM EQ 300MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA206510.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Dutrebis
- Active substance
- lamivudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Merck Sharp Dohme
- Status
- Discontinued
- FDA approval
- 6 Feb 2015
- Application
- NDA206510-001